Chao Ju Ophthalmology
Stage
IPO | IPOTotal Raised
$59.17MDate of IPO
7/7/2021Market Cap
2.44BLatest Chao Ju Ophthalmology News
Jul 8, 2021
Fangda and Harneys advised Chaoju Eye Care Holdings Limited on the deal. Chaoju Eye Care Holdings raised HK$1.36 billion ($175.1 million) in net proceeds from its Hong Kong initial public offering after pricing the shares at the upper limit of the indicative price range. Listing proceeds will go toward acquisition and establishment of new ophthalmic hospitals as well as renovations and upgrades to existing hospitals and IT infrastructure. Chaoju Eye Care is a leading ophthalmology and eye care medical services provider with 17 ophthalmic hospitals and 23 optical centers across the PRC, with a strong foundation in North China and Inner Mongolia. The Fangda team was led by partners Peter Chen (Picture), Christine Chen and Arman Lie and the team members comprised of associates Brian Kwok, Siyu You, Ning Linzy, trainee Lizzie Cheong and paralegal Andrew Chan. The Harneys team comprised of Raymond Ng and Denise Chan, supported by Vicky Lord, Managing Partner, and assisted by Fiduciary Virginia Choy and Jeff Ng.
Where is Chao Ju Ophthalmology's headquarters?
Chao Ju Ophthalmology's headquarters is located at Room 1002, Block A, Fangzhuang Riyue Tiandi Tower, Beijing.
What is Chao Ju Ophthalmology's latest funding round?
Chao Ju Ophthalmology's latest funding round is IPO.
How much did Chao Ju Ophthalmology raise?
Chao Ju Ophthalmology raised a total of $59.17M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.